Evidence map›Paper›PMID 30715741›Full record

ArticleHepatology (Baltimore, Md.)2019

Glial Cell Line-Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity.

Simon Musyoka Mwangi, Ge Li, Lan Ye, Yunshan Liu, Francois Reichardt, Samantha M Yeligar, C Michael Hart, Mark J Czaja, Shanthi Srinivasan

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKα-mTORC1 pathway.Laboratory investigation; a journal of technical methods and pathology · 2022
    Article
  5. Article
  6. Autophagy in liver diseases: A review.Molecular aspects of medicine · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Simon Musyoka MwangiDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Ge LiDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Lan YeDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Yunshan LiuDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Francois ReichardtDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Samantha M YeligarDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
C Michael HartDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Mark J CzajaDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0003-2306-7219
Shanthi SrinivasanDivision of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Emory University · US

Funding

MODULATION OF ACUTE TOXIC LIVER INJURYR01DK044234 · NIDDK · YESHIVA UNIVERSITY · PI SRINIVASAN, SHANTHI K · 1992 to 2023
$7.6M
Mechanism of Enteric NeuropathyR01DK080684 · NIDDK · EMORY UNIVERSITY · PI Shanthi K Srinivasan · 2009 to 2026
$6.1M
Regulation of the innate immune response in alcoholic liver disease by autophagyR01AA022601 · NIAAA · EMORY UNIVERSITY · PI CZAJA, MARK J · 2014 to 2018
$2.1M
Autophagy modulates liver injury and inflammation through cell signaling effectsR56DK044234 · NIDDK · EMORY UNIVERSITY · PI CZAJA, MARK J · 2018 to 2018
$454k
Role of GDNF in the regulation of pancreatic beta cell massI01BX000136 · VA · VETERANS HEALTH ADMINISTRATION · PI Shanthi K Srinivasan · 2009 to 2026
–
BLRD VA I01 BX000136NIAAA NIH HHS R01 AA022601NIDDK NIH HHS R01 DK044234NIDDK NIH HHS R01 DK080684NIDDK NIH HHS R56 DK044234VA Research and Development Merit Review BX000136-08
6 · The paper itself

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is a protein that is required for the development and survival of enteric, sympathetic, and catecholaminergic neurons. We previously reported that GDNF is protective against high fat diet (HFD)-induced hepatic steatosis in mice through suppression of hepatic expression of peroxisome proliferator activated receptor-γ and genes encoding enzymes involved in de novo lipogenesis. We also reported that transgenic overexpression of GDNF in mice prevented the HFD-induced liver accumulation of the autophagy cargo-associated protein p62/sequestosome 1 characteristic of impaired autophagy. Here we investigated the effects of GDNF on hepatic autophagy in response to increased fat load, and on hepatocyte mitochondrial fatty acid β-oxidation and cell survival. GDNF not only prevented the reductions in the liver levels of some key autophagy-related proteins, including Atg5, Atg7, Beclin-1 and LC3A/B-II, seen in HFD-fed control mice, but enhanced their levels after 12 weeks of HFD feeding. In vitro, GDNF accelerated autophagic cargo clearance in primary mouse hepatocytes and a rat hepatocyte cell line, and reduced the phosphorylation of the mechanistic target of rapamycin complex downstream-target p70S6 kinase similar to the autophagy activator rapamycin. GDNF also enhanced mitochondrial fatty acid β-oxidation in primary mouse and rat hepatocytes, and protected against palmitate-induced lipotoxicity. Conclusion: We demonstrate a role for GDNF in enhancing hepatic autophagy and in potentiating mitochondrial function and fatty acid oxidation. Our studies show that GDNF and its receptor agonists could be useful for enhancing hepatocyte survival and protecting against fatty acid-induced hepatic lipotoxicity.

Indexed as

AnimalsAutophagyCell DeathDiet, High-FatDisease Models, AnimalFemaleGlial Cell Line-Derived Neurotrophic FactorHepatocytesHep G2 CellsHumansLipogenesisLipolysisMaleMiceMice, TransgenicNon-alcoholic Fatty Liver DiseaseGDNF protein, humanGlial Cell Line-Derived Neurotrophic FactorPalmitatesSirolimus

Identifiers

PMID30715741
PMCPMC6541506
OpenAlexW2911798425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.